Salute e Benessere

Chance Pharma Announces Commercialization Agreement with Huadong Medicine for…

Mr. Liang Lv, Chairman and General Manager of Huadong Medicine, commented: "We see significant potential for CXG87 in respiratory treatment. This partnership will strategically enhance our respiratory pipeline and, by leveraging our nationwide commercial network and specialized promotion team, will enable CXG87 to achieve rapid market access and broad coverage upon launch. We are dedicated to building a strong and synergistic partnership with Chance, harnessing our respective strengths to…
PR Newswire
09/10/2025

Orexa Announces Positive Interim Data for its Phase 2 Trial in the Prevention of…

The clinical trial (EudraCT number 2022-503113-31-00-IN-002) is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of Orexa's lead compound ORE-001. The Study is enrolling 100 to 120 female patients undergoing gynecologic surgery requiring longitudinal laparotomy. It is being conducted at multiple centers in Germany with lead investigator Prof. Alexander Mustea from Universitätsklinikum Bonn (UKB). The clinical trial (EudraCT number...
PR Newswire
09/10/2025

Resolution Therapeutics announces upcoming presentations at the American…

Dr Paul Brennan MD, PhD, Clinical Lecturer in Hepatology, University of Dundee, UK, will present data from the University of Edinburgh's MATCH 2 clinical trial demonstrating that regenerative macrophage therapy (RMT) is associated with early changes in biomarkers associated with liver function (INR; dMELD), which in turn correlate with much longer survival in patients with advanced cirrhosis. Details below: DrPaul BrennanMD, PhD, Clinical Lecturer in Hepatology,University of Dundee, UK,...
PR Newswire
09/10/2025

Ariceum Therapeutics Data at the 2025 European Association of Nuclear Medicine…

Oral presentation by Dr Zan highlighted novel Phase 1/2 SANTANA-225 study design of 225Ac-SSO110 in patients with ES-SCLC or MCC225Ac-SSO110 achieves superior pharmacokinetics with minimal re-distribution of Actinium-225 daughter isotopes and 100% survival in preclinical studiesInitial safety data from SANTANA-225 expected in 2026 BERLIN, Oct.09, 2025(GLOBE NEWSWIRE) --Ariceum Therapeutics (Ariceum), a targeted radiotherapeutics company dedicated to setting new standards in...
Nasdaq GlobeNewswire
09/10/2025

Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for…

On track to file CTA by year end 2025, with plan to dose first patients and deliver initial data in 2026Planned UK trial to be led by Prof. Fiona Thistlethwaite at The Christie NHS Foundation Trust, a European hub for advanced therapies, with participation from Dr. Andrew Furness at The Royal Marsden, a world-renowned centre for oncology and early-phase clinical research Oslo, Norway, 9 October 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic (“off-the-shelf”) T Cell...
Nasdaq GlobeNewswire
09/10/2025

Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE®…

Pratteln, Switzerland, October 9, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Biomedica for the distribution of AGAMREE® (vamorolone) in Russia, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.Under the terms of the agreement, Santhera will receive a percentage of net sales, in line with previous distribution agreements, with sales expected to begin in Q1 2026. This collaboration will enable...
Nasdaq GlobeNewswire
09/10/2025

Fagron reports solid third quarter performance with 6.4% revenue growth and…

Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 – 7:00 AM CET Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlookFagron, the leading global player in pharmaceutical compounding today publishes its quarterly results for the period ending 30 September 2025. Key Highlights Q3 2025 organic growth at CER1 of 8.5% on a normalized basis2and 5.7% including the GLP-1 impact ...
Nasdaq GlobeNewswire
09/10/2025

Sustainable Footwear Market: Poised to Reach USD 15.9 Billion by 2032, Credence…

What is Driving the Sustainable Footwear Market? What is Driving the Sustainable Footwear Market? The global conversation surrounding environmental protection has become impossible to ignore. Consumers are making lifestyle choices that reflect their values, and brands are under pressure to not only comply with regulations but also cater to ethically and environmentally conscious buyers. Key Market Drivers Eco-Conscious Consumer BehaviorModern consumers especially Generation Z...
PR Newswire
09/10/2025

Hereditary Transthyretin Amyloidosis Market Forecasts Strong Growth Amid New…

Hereditary Transthyretin Amyloidosis Market Summary Hereditary Transthyretin Amyloidosis Market Summary Discover the hereditary transthyretin amyloidosis new treatment @New Treatments for Hereditary Transthyretin Amyloidosis Key Factors Driving the Growth of the Hereditary Transthyretin Amyloidosis Market Advancements in Genetic Testing and Early Diagnosis Improved genetic testing techniques have enhanced the ability to diagnose hATTR at earlier stages. This...
PR Newswire
08/10/2025

Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

"The world is paying attention to brain health and the field of Neurology is positioned to make groundbreaking changes in the way we diagnose, treat, and care for brain disorders around the world," said Prof. Wolfgang Grisold, President, World Federation of Neurology. "Through this Congress, we have a unique opportunity to shift the global trajectory of brain health through education, research, and collaboration, which is the core of the mission of the World Federation of…
PR Newswire
08/10/2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…

Attachment Notification of managers' transaction - Riad Sherif - October 2025 RSU vest
Nasdaq GlobeNewswire
08/10/2025

Boxcar Scars Market to Reach $3.1 billion, Globally, by 2034 at 5.6% CAGR…

These non-surgical or minimally invasive treatments are increasingly sought after by individuals aiming to improve skin texture, tone, and appearance. The market is gaining momentum due to growth in aesthetic awareness, technological advancements in skin rejuvenation devices, and increase in the demand for scar revision among younger populations. Expanding access to dermatological care and the integration of AI-based skin assessment tools are further contributing to market growth. These...
PR Newswire
08/10/2025

Mindfulness Meditation Apps Market Set to Surge from USD 1.2 Billion in 2024 to…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=170472 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=170472 202 - Pages 126 – Tables 37 – Figures Scope Of The Report 1. Market Growth and Size The Mindfulness Meditation Apps Market has experienced remarkable growth in recent years, reaching an estimatedUSD 1.2 billionin 2024. This growth is propelled by rising consumer awareness of...
PR Newswire
08/10/2025

Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034

VANCOUVER, BC, Oct. 8, 2025 /PRNewswire/ -- Ohio Stateresearchers recently solved a critical mystery explaining why some cancer immunotherapies fail[1], while a University of Chicagoteam discovered a common supplement that supercharges immune cells against tumors[2]. These breakthroughs are propelling the global cancer treatment market from $282 billion in 2025 toward $643.5 billion by 2034[3], creating powerful momentum for companies pioneering next-generation approaches including GT Biopharma…
PR Newswire
08/10/2025

Veterinary Medical Devices and Supplies Market worth US$3.60 billion by 2030…

Browse in-depth TOC on "Veterinary Medical Devices and Supplies Market" Browse in-depth TOC on "Veterinary Medical Devices and Supplies Market" 740 - Tables 69 - Figures 568 - Pages By product,In the veterinary medical devices and supplies market, the critical care consumables segment accounted for the largest market share in 2024. This dominance is primarily due to the nature of critical care consumables being indispensable in daily veterinary practice, as they are used...
PR Newswire
08/10/2025

Patient Handling Equipment Market to Reach US$ 26.76 Billion by 2033 Driven by…

The industry is being shaped by increasing elderly populations, rising chronic disease prevalence, home-based care trends, and government emphasis on hospital safety protocols. Leading players such as Stryker, Arjo, Invacare, and Hillrom continue to innovate with ergonomically advanced, IoT-enabled, and automated patient handling systems. The industry is being shaped by increasingelderly populations, rising chronic disease prevalence, home-based care trends, and government emphasis on...
PR Newswire
08/10/2025

Dental Implants Market to Reach USD 15.14 Billion by 2035, Growing At a 9.95%…

For investors, the market represents a convergence of medtech innovation and digital scalability, offering strong long-term growth visibility. The rapid expansion of dental service organizations (DSOs), cloud-based implant planning, and AI-driven production platforms is unlocking new recurring revenue models. Strategic investments in premium implant systems, emerging Asia-Pacific dental tourism corridors, and AI-integrated manufacturing are expected to yield robust portfolio returns through…
PR Newswire
08/10/2025

WHO Prequalifies Shanchol® Oral Cholera Vaccine, Ensuring Global Supply…

Over the years, close to 40 million doses of Shanchol® have been supplied worldwide through UNICEF-led vaccination campaigns. After production was paused under its former ownership, GCBC Vaccines Pvt. Ltd. (formerly Shantha) has resumed manufacturing, with WHO conducting an on-site inspection and transferring the prequalification. Shanchol® remains the only oral cholera vaccine manufactured in India with WHO prequalification, underscoring India's critical role in ensuring continuity of global…
PR Newswire
08/10/2025

India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals…

In this study, the researchers, using systems-level multi-omic approaches, showed how genetic variants in yeast work together to activate previously dormant metabolic pathways. By revealing how these gene–gene interactions dynamically rewire metabolism, the study provides a powerful framework for decoding how multiple genes combine to modify and improve complex phenotypes. In this study, the researchers, using systems-level multi-omic approaches, showed how genetic variants in yeast work...
PR Newswire
08/10/2025

Public Interest Registry Unveils Winners of 7th Annual .ORG Impact Awards at DC…

Common, the first rapper to win a Grammy, Oscar and Emmy award and star of the Apple TV+ show Silo, hosted this year's event where PIR awarded a total of $180,000 in donations to organizations from the global .ORG Community across seven categories: Common, the first rapper to win a Grammy, Oscar and Emmy award and star of the Apple TV+ showSilo,hosted this year's event where PIR awarded a total of$180,000in donations to organizations from the global.ORG Community across seven...
PR Newswire
08/10/2025

European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology…

"This is a landmark achievement for our company," said Markus Hörer, Ascend's Chief Scientific Officer. "By defending our EpyQ® patent, we have not only secured our innovation but also reinforced our position as a leader in AAV plasmid technology. This decision strengthens our ability to support partners in advancing gene therapy development with confidence in the IP landscape." "This is a landmark achievement for our company," said Markus Hörer, Ascend's Chief…
PR Newswire
08/10/2025

Evaxion expands AI-Immunology™ platform with automated vaccine design module

New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior in vaccine target discovery, now also enables enhanced design applicable for both new vaccines and optimization of approved onesEvaxion will present detailed validation data on these improvements at theWorld Vaccine Congress Europe in Amsterdam on October 15, 2025COPENHAGEN, Denmark, October 8,...
Nasdaq GlobeNewswire
08/10/2025

BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS

Before joining Sanofi Pasteur-Canada in 1999, Dr. Tartaglia was Executive Director of Research at Virogenetics Corporation of Troy, New York, a former subsidiary of Sanofi Pasteur. At Virogenetics he helped develop the poxvirus vector technology as an immunization vehicle for both veterinary and human application, including HIV and cancer. Prior to joining Virogenetics in 1990, Jim worked as a research scientist with the New York State Department of Health and was a postdoctoral fellow at the…
PR Newswire
08/10/2025

Invitation: Sobi's Q3 2025 report

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call. The presentation can be followed livehere or afterwards on sobi.com. The slides will be made available onsobi.com before the conference call. To participate in the conference call, please use the following dial-in details: Sweden : +46 8 5051 0031United Kingdom : +44 207 107 06 13United States : +1 631 570 56 13 For other countries,...
PR Newswire
08/10/2025
Altri  Comunicati